Sentence examples for multiple sclerosis remains from inspiring English sources

What drives chronic and progressive disease in multiple sclerosis remains unresolved.

Currently the evidence for the presence of EBV-infected cells in the brain of patients with multiple sclerosis remains controversial.

While these new treatments are promising, the development of therapies for patients with progressive multiple sclerosis remains a significant challenge.

Although the exact aetiology of multiple sclerosis remains unknown, it is widely accepted that the activation of myelin-specific CD4+ T cells is a central step in the initiation of neuroinflammation (Sospedra and Martin, 2005).

How and if this anti-EBNA1 immune response reflects or contributes to inflammation in multiple sclerosis remains to be determined, but aberrant EBNA1 reactivity has been suggested as surrogate marker for multiple sclerosis risk (Lünemann and Munz, 2009; Ascherio and Munger, 2010, Simon et al., 2010).

Quite why impaired IL7R signalling increases the risk of developing multiple sclerosis remains unknown, and of course it is always possible that the effect of this variant on IL7 signalling is an epiphenomenon with some other as yet untested function of this gene being more relevant to susceptibility.

Treatment of chronic neurodegenerative diseases such as multiple sclerosis (MS) remains a major challenge.

Although the etiology of multiple sclerosis (MS) remains uncertain, clinical, epidemiological, and laboratory findings suggest that environmental factors may be involved in the disease.

Cortisol is a key regulator of the immune system, energy metabolism, and stress, yet its relevance to fatigue experienced by people with relapsing-remitting multiple sclerosis (RRMS) remains uncertain.

Despite clear advances in research and treatment [ 1] Multiple Sclerosis (MS) remains a chronic, inflammatory, incurable disease of the central nervous system.

Neutrophil infiltration into the CNS has been implicated in CNS diseases involving an inflammatory reaction (e.g., bacterial meningitis) (Ransohoff and Brown, 2012), however, whether this migration takes place under chronic neuroinflammatory conditions (e.g., multiple sclerosis and AD) remains unknown.